Myriad Genetics (MYGN) EBT Margin (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly EBT Margin of 17.02% for Q1 2026, down 201.0% YoY from 16.85% in Q1 2025, and down 301.12% sequentially from 4.24% in Q4 2025.
Myriad Genetics (MYGN) EBT Margin (2009 - 2026) Analysis & Trends
Myriad Genetics has disclosed EBT Margin across 18 years of filings, most recently posting 17.02% for Q1 2026.
- In Q1 2026, EBT Margin fell 201.0% year-over-year to 17.02%; the TTM figure through Mar 2026 stood at 48.23% (down 3296.0% YoY), while the FY2025 annual figure was 47.92%, down 3318.0% from the prior year.
- EBT Margin declined to 17.02% in Q1 2026, from 4.24% in the prior quarter.
- Over the last five years, EBT Margin for MYGN reached as high as 4.24% in Q4 2025 and fell as low as 155.14% in Q2 2025.
- The 5-year median for EBT Margin is 17.02% (2026), against an average of 28.66%.
- Annual changes were most pronounced in 2024 — EBT Margin surged 4568 bps — and 2025, when it tumbled 13755 bps.
- A 5-year view of EBT Margin shows it stood at 29.3% in 2022, then soared by 44 bps to 16.43% in 2023, then fell by 13 bps to 18.57% in 2024, then surged by 77 bps to 4.24% in 2025, then tumbled by 301 bps to 17.02% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 17.02%, 4.24%, and 12.74% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.16% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -12.17% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 22.23% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 7.90% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 22.14% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -17.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.02% |
| Dec 31, 2025 | -4.24% |
| Sep 30, 2025 | -12.74% |
| Jun 30, 2025 | -155.14% |
| Mar 31, 2025 | -15.01% |
| Dec 31, 2024 | -18.57% |
| Sep 30, 2024 | -9.94% |
| Jun 30, 2024 | -17.59% |
| Mar 31, 2024 | -12.81% |
| Dec 31, 2023 | -16.43% |
| Sep 30, 2023 | -31.89% |
| Jun 30, 2023 | -63.27% |
| Mar 31, 2023 | -29.03% |
| Dec 31, 2022 | -29.30% |
| Sep 30, 2022 | -28.26% |
| Jun 30, 2022 | -9.98% |
| Mar 31, 2022 | -16.01% |
| Dec 31, 2021 | -27.05% |
| Sep 30, 2021 | 23.79% |
| Jun 30, 2021 | -2.01% |